GlassScriptPhysician profile
Laura Holliger
NPI 1437605409
$10,151.76
in general payments reported to CMS, 2019-2025
53 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what 92% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,542 · 2022: $2,188 · 2023: $2,105 · 2024: $1,881 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,421.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,762.49 | 2021-2025 | |
| Pfizer INC. | $755.94 | 2021-2025 | |
| Novo Nordisk INC | $739.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $720.51 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $526.55 | 2021-2025 | Ofev, Jardiance, Jascayd |
| Glaxosmithkline, LLC. | $478.72 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $448.94 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Daiichi Sankyo INC. | $354.06 | 2021-2025 | Injectafer |
| Merck Sharp & Dohme LLC | $353.85 | 2021-2024 | Verquvo, Belsomra, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $284.78 | 2021-2025 | |
| Astellas Pharma US INC | $255.12 | 2021-2025 | Veozah |
| Corcept Therapeutics | $247.71 | 2021-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $244.43 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $220.60 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $213.10 | 2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $182.37 | 2021-2025 | Ajovy, Austedo Xr |
| Amgen INC. | $177.08 | 2022-2025 | Evenity, Prolia, Otezla |
| Amarin Pharma, INC. | $166.41 | 2021-2023 | |
| Dexcom, INC. | $153.11 | 2022-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $146.24 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.98 | 2021-2025 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $136.83 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $114.96 | 2021-2024 | Xarelto |
| Idorsia Pharmaceuticals US INC | $95.89 | 2022-2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $91.65 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $88.68 | 2023-2024 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $84.17 | 2023-2024 | Rexulti, Jynarque |
| Aimmune Therapeutics, INC. | $76.66 | 2024-2025 | Zenpep |
| Takeda Pharmaceuticals U.S.A., INC. | $70.93 | 2021-2023 | Trintellix |
| Neurocrine Biosciences, INC. | $68.57 | 2024-2025 | Ingrezza |
| Kowa Pharmaceuticals America, INC. | $60.24 | 2021-2022 | |
| Optinose US, INC. | $59.94 | 2024-2025 | |
| Axsome Therapeutics, INC. | $51.94 | 2025 | Auvelity |
| Vivus LLC | $49.63 | 2024-2025 | Qsymia |
| Seqirus USA INC | $48.13 | 2022-2025 | Flucelvax, Fluad |
| E.R. Squibb & Sons, L.L.C. | $45.04 | 2023 | Eliquis, Camzyos |
| Sumitomo Pharma America, INC. | $42.95 | 2024-2025 | Gemtesa |
| Azurity Pharmaceuticals, INC. | $39.10 | 2024 | Edarbyclor |
| Ironwood Pharmaceuticals, INC | $36.71 | 2021 | |
| Eisai INC. | $35.05 | 2021 | |
| Ardelyx, INC. | $33.43 | 2024 | Ibsrela |
| Jazz Pharmaceuticals INC. | $32.72 | 2021 | |
| Arbor Pharmaceuticals, INC. | $32.20 | 2021 | |
| Abbott Laboratories | $30.39 | 2022-2024 | Freestyle Libre 3 |
| Tonix Medicines, INC. | $23.05 | 2025 | Tonmya |
| Lundbeck LLC | $21.95 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $18.59 | 2022 | |
| Biogen, INC. | $18.22 | 2022 | |
| Horizon Therapeutics Plc | $16.84 | 2023 | Krystexxa |
| Almatica Pharma LLC | $15.21 | 2022 | |
| Sanofi Pasteur INC. | $13.86 | 2022 | |
| Sunovion Pharmaceuticals INC. | $10.65 | 2021 | |
| Phathom Pharmaceuticals, INC. | $9.69 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Holliger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.